A Model for Prediction of Cisplatin Induced Nephrotoxicity by Kidney Weight in Experimental Rats

Overview

Journal J Res Med Sci

Specialty General Medicine

Date 2013 Nov 1

PMID 24174938

Citations 21

Authors

Mehdi Nematbakhsh

Farzaneh Ashrafi

Hamid Nasri

Ardeshir Talebi

Zahra Pezeshki

Fatemeh Eshraghi

Maryam Haghighi

Affiliations

Soon will be listed here.

Abstract

Background: Cisplatin (cis-diamminedichloroplatinum II; CP) is used widely as an antitumor drug in clinics, but is accompanied with renal toxicity. Cisplatin induced nephrotoxicity consists of change in kidney weight, histological changes in kidney and increase in serum creatinine (Cr) and blood urea nitrogen (BUN). This study was designed to find out a model for prediction of cisplatin induced nephrotoxicity.

Materials And Methods: Pathological damage score, kidney weight, BUN, and Cr of 227 rats that were involved in different projects were determined. A total of 187 rats were treated with 7 mg/kg cisplatin and sacrificed 1 week later.

Results: There was a good significant correlation between normalized kidney weight and logarithmic scale of BUN and Cr. Relationship between BUN, Cr or normalized kidney weight and pathology damage score was significant.

Conclusion: Normalized kidney weight and pathology damage score is a good predictor of renal function in cisplatin induced nephrotoxicity in experimental rats.

Citing Articles

A low-dose pemetrexed-cisplatin combination regimen induces significant nephrotoxicity in mice.

Iwhiwhu S, Kumar R, Khan A, Afolabi J, Williams J, de la Cruz J BMC Nephrol. 2024; 25(1):370.

PMID: 39434019 PMC: 11494951. DOI: 10.1186/s12882-024-03822-5.

Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats.

Farrokh-Eslamlou N, Momtaz S, Niknejad A, Hosseini Y, Mahdaviani P, Ghasemnejad-Berenji M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):7061-7070.

PMID: 38643451 DOI: 10.1007/s00210-024-03088-6.

Ameliorative Effect of Leaf Extract on Cisplatin-Induced Nephrotoxicity in the Rat Model.

Ibrahim D, Halboup A, Al Ashwal M, Shamsher A Int J Nephrol. 2023; 2023:2074498.

PMID: 37497380 PMC: 10368505. DOI: 10.1155/2023/2074498.

Tumor necrosis factor-alpha antibody labeled-polyethylene glycol-coated nanoparticles: A mesenchymal stem cells-based drug delivery system in the rat model of cisplatin-induced nephrotoxicity.

Abo-Aziza F, Albarrak S, Zaki A, El-Shafey S Vet World. 2022; 15(10):2475-2490.

PMID: 36425134 PMC: 9682403. DOI: 10.14202/vetworld.2022.2475-2490.

Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD-Dependent Enzymes and Plant-Derived Natural Products.

Iskander A, Yan L Biomolecules. 2022; 12(8).

PMID: 36008971 PMC: 9405866. DOI: 10.3390/biom12081078.

References

Wilson D, Honrath U . Collecting duct function in cis-platinum nephrotoxicity. Can J Physiol Pharmacol. 1987; 65(6):1200-4. DOI: 10.1139/y87-189. View

Arany I, Safirstein R . Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23(5):460-4. DOI: 10.1016/s0270-9295(03)00089-5. View

Choie D, Longnecker D, del Campo A . Acute and chronic cisplatin nephropathy in rats. Lab Invest. 1981; 44(5):397-402. View

Miller R, Tadagavadi R, Ramesh G, Reeves W . Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2011; 2(11):2490-518. PMC: 3153174. DOI: 10.3390/toxins2112490. View

Salama R . Matricaria chamomilla attenuates cisplatin nephrotoxicity. Saudi J Kidney Dis Transpl. 2012; 23(4):765-72. DOI: 10.4103/1319-2442.98158. View

Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C . Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity. Am J Physiol. 1981; 241(2):F175-85. DOI: 10.1152/ajprenal.1981.241.2.F175. View

Nosaka K, Nakada J, Endou H . Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats. Kidney Int. 1992; 41(1):73-9. DOI: 10.1038/ki.1992.10. View

Nematbakhsh M, Ashrafi F, Safari T, Talebi A, Nasri H, Mortazavi M . Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats. J Nephrol. 2011; 25(3):410-7. DOI: 10.5301/jn.5000018. View

Saad S, Al-Rikabi A . Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy. 2002; 48(1):42-8. DOI: 10.1159/000048587. View

10.

Vickers A, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P . Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol. 2004; 32(5):577-90. DOI: 10.1080/01926230490508821. View

11.

Haghighi M, Nematbakhsh M, Talebi A, Nasri H, Ashrafi F, Roshanaei K . The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences. Ren Fail. 2012; 34(8):1046-51. DOI: 10.3109/0886022X.2012.700886. View

12.

Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T . Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull. 2005; 28(9):1635-8. DOI: 10.1248/bpb.28.1635. View

13.

Yao X, Panichpisal K, Kurtzman N, Nugent K . Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007; 334(2):115-24. DOI: 10.1097/MAJ.0b013e31812dfe1e. View

14.

Saad S, Najjar T, Daba M, Al-Rikabi A . Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy. 2003; 48(6):309-15. DOI: 10.1159/000069714. View